Shares of Castlight Health Inc. (NYSE:CSLT) have received an average rating of “Hold” from the nine ratings firms that are presently covering the firm. Six research analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $4.79.

CSLT has been the topic of a number of research analyst reports. FBR & Co reiterated a “hold” rating and set a $4.00 target price on shares of Castlight Health in a research report on Wednesday, August 10th. Canaccord Genuity reiterated a “hold” rating and set a $5.00 target price on shares of Castlight Health in a research report on Thursday, August 11th. Zacks Investment Research upgraded Castlight Health from a “hold” rating to a “buy” rating and set a $5.00 target price on the stock in a research report on Friday, August 12th. Finally, Morgan Stanley reiterated a “hold” rating and set a $4.00 target price on shares of Castlight Health in a research report on Thursday, August 25th.

In other Castlight Health news, CRO John Mccracken sold 5,570 shares of Castlight Health stock in a transaction that occurred on Friday, November 18th. The stock was sold at an average price of $4.81, for a total value of $26,791.70. Following the sale, the executive now owns 20,000 shares of the company’s stock, valued at approximately $96,200. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Jonathan Rende sold 7,794 shares of Castlight Health stock in a transaction that occurred on Wednesday, November 16th. The shares were sold at an average price of $4.99, for a total value of $38,892.06. Following the completion of the sale, the insider now directly owns 82,818 shares in the company, valued at approximately $413,261.82. The disclosure for this sale can be found here. 37.43% of the stock is owned by company insiders.

Large investors have recently made changes to their positions in the stock. Prescott Group Capital Management L.L.C. raised its stake in shares of Castlight Health by 61.8% in the second quarter. Prescott Group Capital Management L.L.C. now owns 241,682 shares of the company’s stock worth $957,000 after buying an additional 92,282 shares in the last quarter. Bank of New York Mellon Corp raised its stake in shares of Castlight Health by 13.1% in the second quarter. Bank of New York Mellon Corp now owns 169,786 shares of the company’s stock worth $672,000 after buying an additional 19,615 shares in the last quarter. California State Teachers Retirement System raised its stake in shares of Castlight Health by 16.7% in the second quarter. California State Teachers Retirement System now owns 84,599 shares of the company’s stock worth $335,000 after buying an additional 12,117 shares in the last quarter. Concourse Capital Management LLC raised its stake in shares of Castlight Health by 13.4% in the second quarter. Concourse Capital Management LLC now owns 68,286 shares of the company’s stock worth $270,000 after buying an additional 8,046 shares in the last quarter. Finally, Westpac Banking Corp acquired a new stake in shares of Castlight Health during the second quarter worth $639,000. 50.75% of the stock is currently owned by institutional investors.

Castlight Health (NYSE:CSLT) opened at 4.85 on Thursday. The firm’s market cap is $502.96 million. Castlight Health has a one year low of $2.54 and a one year high of $5.15. The firm’s 50 day moving average price is $4.30 and its 200-day moving average price is $4.16.

Castlight Health (NYSE:CSLT) last posted its earnings results on Wednesday, November 2nd. The company reported ($0.05) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.09) by $0.04. Castlight Health had a negative return on equity of 58.57% and a negative net margin of 73.57%. The business had revenue of $25.50 million for the quarter, compared to analysts’ expectations of $24.81 million. During the same quarter in the previous year, the firm earned ($0.17) earnings per share. The business’s revenue was up 30.8% compared to the same quarter last year. Equities analysts predict that Castlight Health will post ($0.34) EPS for the current fiscal year.

About Castlight Health

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its products deliver employee engagement and enable employers to integrate benefit programs into a single platform available to employees and their families.

5 Day Chart for NYSE:CSLT

Receive News & Stock Ratings for Castlight Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health Inc. and related stocks with our FREE daily email newsletter.